Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors
Clinical trial NCT03006887 · COMPLETED
Trial details
- NCT number
- NCT03006887
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-12
- Primary completion
- 2020-04-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.